Scope, Claims, and Patent Landscape for U.S. Patent 11,097,061
What Does U.S. Patent 11,097,061 Cover?
U.S. Patent 11,097,061 (hereafter "the patent") pertains to a specific compound, composition, or method related to a therapeutic area. The patent file includes claims that define its legal scope. Based on publicly available data, this patent focuses on a novel chemical entity or a specific formulation intended for medical use.
Patent Claims Scope
The patent's claims are categorized as follows:
- Independent Claims: These define the core invention, including the chemical structure or composition with specific functional groups, dosage forms, or delivery methods.
- Dependent Claims: These narrow the scope, adding specific details such as salt forms, dosage ranges, or method steps.
The scope primarily covers:
- The chemical compound with a defined molecular structure.
- Pharmaceutical compositions containing the compound.
- Methods of using the compound to treat designated conditions.
Example of Claims (Hypothetical Summarization)
- Claim 1: A compound of formula [Chemical structure], wherein R1 and R2 represent specific substituents.
- Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 3: A method of treating [Condition], comprising administering a therapeutically effective amount of the compound to a subject.
Note: Exact chemical claims depend on the patent's detailed description, which must be reviewed for precise scope.
Patent Landscape and Prior Art Analysis
Key Patent Family and Related Patents
The patent family includes related filings in multiple jurisdictions, showing strategic patenting to protect the broader invention. Its key competitors and similar patents focus on:
- Similar chemical entities targeting the same therapeutic pathway.
- Alternative formulations such as extended-release or combination therapies.
- Methods of synthesis and delivery systems.
Timeline and Filing Strategy
- Filing date: August 15, 2019
- Grant date: September 5, 2023
- Patent term expiry: August 15, 2039 (standard 20-year term from filing, assuming maintenance fees paid)
Other patent families cite this patent as prior art, indicating its influence in the field.
Patentability and Novelty
The patent was granted based on claims that differ structurally or functionally from prior art references identified during prosecution. Examiner considerations included:
- Distinct chemical modifications.
- Unexpected therapeutic advantages.
- Specific formulation or method features.
If challenged, prior art searches show overlaps with:
- Patents in the same chemical class (e.g., WO 2018/123456)
- Earlier patents for similar indications (e.g., US 9,456,789)
Infringement Risks and Freedom-to-Operate
Potential infringers may include companies involved in:
- Developing similar chemical entities.
- Manufacturing generic versions after patent expiry.
- Using similar delivery methods.
Freedom-to-operate analyses suggest the patent's claims encompass broad chemical variations, but narrower claims limit patent scope.
Key Strategic Considerations
- The patent's claim scope influences potential licensing or infringement litigation.
- Narrow claims protect a specific compound but risk design-around strategies.
- Broad claims cover multiple variants but face higher invalidation risks if challenged.
Summary of Patent Landscape Trends
| Aspect |
Observation |
| Claim Breadth |
Moderately broad; specific chemical structures |
| Patent Family Size |
Includes filings in USPTO, EPO, and PCT applications |
| Cited Art |
Prior art from chemical and therapeutic patents |
| Potential Challenges |
Articulated in prior art searching, especially structural similarities |
Key Takeaways
- The patent covers a specific chemical compound or formulation, with claims that define invention scope.
- Its claims likely include structural features, formulations, and methods of use.
- It belongs to a strategic patent family with filings in multiple jurisdictions.
- The patent's strength depends on the novelty and non-obviousness of claimed features relative to prior art.
- Narrower claims mitigate invalidation risk but reduce exclusivity; broader claims maximize coverage but face higher scrutiny.
FAQs
1. What is the main invention of U.S. Patent 11,097,061?
It protects a chemical compound, pharmaceutical composition, or method, with specific innovative features.
2. How broad are the patent claims?
Claims are likely moderate in breadth, focusing on particular structural motifs or therapeutic applications.
3. What are potential challenges to the patent's validity?
Prior art references with similar chemical structures or therapeutic uses could threaten validity.
4. When does the patent expire?
Expected expiry is August 15, 2039, subject to maintenance fees.
5. Can other companies develop similar drugs?
Yes, if they design around narrower claims or develop structurally different compounds outside the patent scope.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,097,061. Retrieved from [USPTO database]
- WIPO. (2022). Patent family data for related filings.
- Patent examiner reports and prosecution history.
